Project Summary

Background: Posttraumatic stress disorder (PTSD) is a complex psychiatric condition experienced by a staggering proportion of our veteran population, affecting approximately 30 percent of the more than 20 million veterans in the United States. PTSD and its sequelae exhibit differently in people and there is no “one size fits all” PTSD treatment. Therefore, it is important for veterans and clinicians to have access, motivation and ability to use and adopt current PTSD treatment evidence for better-informed healthcare decision making. 

Proposed Solution to the Problem: On the Double, a veteran-driven dissemination campaign (VDC) will be launched across the United States to spread awareness and actively disseminate available PCORI-funded research on psychological and pharmacological treatment options for PTSD to increase the reach of evidence to veterans and the clinicians who treat them.

Objectives: Disseminate evidence on PTSD treatment options in the veteran community for rapid uptake using ways that will command their attention and draw interest; launch the VDC; spread awareness and increase knowledge of PTSD treatment options; increase the reach (social media/network, workshops, podcasts), motivation (community leaders/groups/experts to stimulate the evidence being disseminated) and ability to use and apply the evidence (easy-to-understand infographics/workshops).

Activities: Mobilize PCOR-Dissemination Team (PCOR-DT), launch VDC, generate tailored veteran-vetted communication approaches via traditional and nontraditional strategies, disseminate evidence on PTSD treatment options via multimodal approaches, produce deliverables including the Veteran-driven Dissemination Campaign Toolkit, evaluate project through ongoing formative evaluations.

Projected Outcomes and Outputs:

Short-term outcomes during the project period:

  • Increase the reach of evidence (100,000 people)
  • Host 20 On the Double Workshops (200 or more people)
  • Demonstrate a 75 percent increase in knowledge of treatment options with a pre-/post-test
  • Disseminate Evidence Updates and easy-to-understand infographics on evidence-based PTSD treatment options to the veteran community

Medium-term outcomes (0-2 years post project period): 

  • Increase the veteran community’s motivation to use/apply evidence: available recorded workshops; on-demand, easy-to-understand infographics; and targeted veteran-centered presentations and publications in open access journals

Long-term outcomes (3+ years post project period): 

  • Increase veterans’ ability to adopt the evidence to improve their health and PTSD symptom severity (interviews) and engage in patient-centered outcomes research/comparative clinical effectiveness research (informal polling/comments)

Patient and Stakeholder Engagement Plan: (PCOR-DT) members (N=10) are made up of veterans, clinicians, researchers and community stakeholders with trusted ties in the veteran community. 

Preexisting engagement: Project lead’s Canines Providing Assistance to Wounded Warriors (C-P.A.W.W.) and community partners have strong ties to the veteran community to spread awareness and increase knowledge of PCOR-funded research findings. 

How: Interactive communication/dissemination plans and targeted messages via social/print media. PCOR-DT meets monthly. 

Stakeholder engagement: Ongoing throughout the project and beyond.

Project Collaborators: South Texas Research Organizational Network Guiding Studies on Trauma and Resilience (STRONG STAR) Consortium to Alleviate PTSD, PTSD Foundation of America-Southern California Chapter, Warrior Built Foundation, Grey Team, One Tribe Foundation, Student Veterans of America, C-P.A.W.W., West Palm Beach and San Francisco VA Medical Centers

Project Information

Cheryl A. Krause-Parello, BSN, MSN, PHD, RN
Beth Pratt , BA, BSN, MS, MSN, PhD, RN
Florida Atlantic University

Key Dates

October 2025


Project Status
State State The state where the project originates, or where the primary institution or organization is located. View Glossary
Last updated: April 3, 2024